Literature DB >> 3265422

Distribution of corticotropin-releasing-factor-like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): an immunohistochemical study.

S L Foote1, C I Cha.   

Abstract

Immunohistochemical methods were utilized to systematically map the distribution of corticotropin-releasing-factor-like immunoreactivity (CRF-LI) in the diencephalon, mesencephalon, and rhombencephalon of two monkey species (Saimiri sciureus and Macaca fascicularis). A primary antiserum directed against the human form of the peptide was utilized. Immunoreactive neuronal perikarya and processes were evident in numerous areas, and the distributions of these elements were similar for the two species. As previously reported for rats, monkeys, and human, intense immunoreactivity was evident in putative hypophyseal neurons in the parvicellular component of the paraventricular nucleus of the hypothalamus and in fibers extending from this area into the median eminence. The results for other brainstem regions, most of which have been previously examined for CRF-LI only in rats, indicate that many similarities exist between rats and monkeys in the distribution of this peptide in brainstem extrahypophyseal neuronal circuits, although substantial differences are also evident. For example, immunoreactive perikarya previously observed in other hypothalamic nuclei in rats were not evident in monkeys. Conversely, in monkeys, unlike rats, labeled perikarya were evident in several thalamic nuclei, especially in the intralaminar complex. Also, two large groups of immunoreactive neurons which have generally not been observed in rat studies were present in the mesencephalon and rhombencephalon. In the mesencephalon this consisted of a group of neurons just lateral to the mesencephalic tegmentum, extending throughout the rostral-caudal extent of the midbrain. In the rhombencephalon, labeled perikarya were observed throughout the inferior olive. Some of the differences between rats and monkeys in the locations of labeled perikarya may be due to differences in antiserum specificity and/or sensitivity, or they may result from the fact that colchicine pretreatment was not utilized in the present study. The distributions of immunoreactive fibers also exhibited similarities and differences between monkeys and rats. The most striking terminal fields observed in the present study which have not been previously described are a moderate-to-dense field within and adjacent to presumed dopamine-containing neurons in the substantia nigra pars compacta, a dense innervation of certain subdivisions of the interpeduncular nucleus, and a regionally and parasagittally organized distribution of fibers in the Purkinje cell and molecular layers of the cerebellar cortex.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265422     DOI: 10.1002/cne.902760208

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  17 in total

1.  Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons.

Authors:  A L Curtis; R J Valentino
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Pattern of maternal circulating CRH in laboratory-housed squirrel and owl monkeys.

Authors:  M L Power; L E Williams; S V Gibson; J Schulkin; J Helfers; E P Zorrilla
Journal:  Am J Primatol       Date:  2010-11       Impact factor: 2.371

3.  Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus.

Authors:  Maria Waselus; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2007-08-14       Impact factor: 3.252

4.  CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons.

Authors:  Arthur C Riegel; John T Williams
Journal:  Neuron       Date:  2008-02-28       Impact factor: 17.173

Review 5.  The neuroanatomic complexity of the CRF and DA systems and their interface: What we still don't know.

Authors:  E A Kelly; J L Fudge
Journal:  Neurosci Biobehav Rev       Date:  2018-04-25       Impact factor: 8.989

Review 6.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

7.  Overexpressing Corticotropin-Releasing Factor in the Primate Amygdala Increases Anxious Temperament and Alters Its Neural Circuit.

Authors:  Ned H Kalin; Andrew S Fox; Rothem Kovner; Marissa K Riedel; Eva M Fekete; Patrick H Roseboom; Do P M Tromp; Benjamin P Grabow; Miles E Olsen; Ethan K Brodsky; Daniel R McFarlin; Andrew L Alexander; Marina E Emborg; Walter F Block; Julie L Fudge; Jonathan A Oler
Journal:  Biol Psychiatry       Date:  2016-01-30       Impact factor: 13.382

8.  Developmental profile of corticotropin releasing hormone messenger RNA in the rat inferior olive.

Authors:  D Chang; S J Yi; T Z Baram
Journal:  Int J Dev Neurosci       Date:  1996-02       Impact factor: 2.457

Review 9.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

10.  Overexpression of corticotropin-releasing factor in Barrington's nucleus neurons by adeno-associated viral transduction: effects on bladder function and behavior.

Authors:  Kile McFadden; Tagan A Griffin; Valerie Levy; John H Wolfe; Rita J Valentino
Journal:  Eur J Neurosci       Date:  2012-08-08       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.